11-Keto-?-Boswellic Acid, a Novel Triterpenoid from Boswellia spp. with Chemotaxonomic Potential and Antitumor Activity against Triple-Negative Breast Cancer Cells.
Ontology highlight
ABSTRACT: Boswellic acids, and particularly 11-keto-boswellic acids, triterpenoids derived from the genus Boswellia (Burseraceae), are known for their anti-inflammatory and potential antitumor efficacy. Although boswellic acids generally occur as ?-isomers (oleanane type) and ?-isomers (ursane type), 11-keto-boswellic acid (KBA) was found only as the ?-isomer, ?-KBA. Here, the existence and natural occurrence of the respective ?-isomer, 11-keto-?-boswellic acid (?-KBA), is demonstrated for the first time. Initially, ?-KBA was synthesized and characterized by high-resolution mass spectrometry (HR-MS) and nuclear magnetic resonance (NMR) spectroscopy, and a highly selective, sensitive, and accurate high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) method was developed by Design of Experiments (DoE) using a pentafluorophenyl stationary phase. This method allowed the selective quantification of individual 11-keto-boswellic acids and provided evidence for ?-KBA in Boswellia spp. oleogum resins. The contents of ?-KBA as well as further boswellic acids and the composition of essential oils were used to chemotaxonomically classify 41 Boswellia oleogum resins from 9 different species. Moreover, ?-KBA exhibited cytotoxicity against three treatment-resistant triple-negative breast cancer (TNBC) cell lines in vitro and also induced apoptosis in MDA-MB-231 xenografts in vivo. The respective ?-isomer and the acetylated form demonstrate higher cytotoxic efficacies against TNBC cells. This provides further insights into the structure-activity relationship of boswellic acids and could support future developments of potential anti-inflammatory and antitumor drugs.
SUBMITTER: Schmiech M
PROVIDER: S-EPMC7828217 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA